The "typical" immunophenotype of acute promyelocytic leukemia (APL-M3): does it prove true for the M3-variant?

M Exner1, R Thalhammer, S Kapiotis

  • 1Department of Laboratory Medicine, University of Vienna, Austria.

Cytometry
|May 8, 2000
PubMed

Insights

This study examined acute promyelocytic leukemia (APL) immunophenotypes. Microgranular APL variants showed diverse immune markers, unlike typical hypergranular APL, suggesting heterogeneity.

Area of Science:

  • Hematology
  • Immunology
  • Oncology

Background:

  • Acute promyelocytic leukemia (APL) is a subtype of acute myeloid leukemia.
  • APL is characterized by the PML-RAR-alpha fusion gene.
  • Immunophenotyping aids in classifying leukemia subtypes.

Purpose of the Study:

  • To present the immunophenotypes of 12 acute promyelocytic leukemias (APL-M3) with the PML-RAR-alpha fusion gene.
  • To compare the immunophenotypic profiles of hypergranular APL and microgranular APL variants.

Main Methods:

  • Immunophenotyping of bone marrow mononuclear cells from 12 APL patients.
  • Utilized a panel of 20 monoclonal antibodies.
  • Analyzed expression of various cell surface antigens.

Main Results:

  • Hypergranular APL cases displayed a mature myeloid phenotype, consistent with M3 classification.
  • Microgranular APL variants showed immunophenotypic heterogeneity.
  • Microgranular APL cases frequently expressed CD34, HLA-DR, and CD2 antigens.

Conclusions:

  • Microgranular APL represents a heterogeneous entity.
  • Immunophenotypic differences exist between hypergranular and microgranular APL subtypes.
  • Further investigation into microgranular APL immunophenotypes is warranted.